Bio-Techne (TECH) Current Assets (2009 - 2026)
Bio-Techne's (TECH) quarterly Current Assets came in at $688.0 million in Q1 2026, up 9.69% year-on-year from $627.2 million in Q1 2025, and up 7.94% quarter-over-quarter from $637.4 million in Q4 2025.
Bio-Techne (TECH) Current Assets (2009 - 2026) Analysis & Trends
Bio-Techne's Current Assets history runs 18 years deep, the most recent figure standing at $688.0 million for Q1 2026.
- On a quarterly basis, Current Assets rose 9.69% year-over-year to $688.0 million in Q1 2026; TTM through Mar 2026 was $688.0 million, a 9.69% increase from a year earlier, with the FY2025 full-year figure at $608.3 million, down 1.48% from the prior year.
- Current Assets grew to $688.0 million in Q1 2026 per TECH's latest filing, from $637.4 million in the prior quarter.
- Across five years, Current Assets topped out at $688.0 million in Q1 2026 and bottomed at $552.0 million in Q3 2022.
- The 5-year median for Current Assets is $609.5 million (2025), against an average of $610.1 million.
- Across the five-year window, Current Assets rose 18.6% in 2022 and dropped 6.02% in 2025, its largest moves.
- Year by year, Current Assets stood at $565.2 million in 2022, then grew by 4.5% to $590.6 million in 2023, then increased by 7.45% to $634.6 million in 2024, then advanced by 0.44% to $637.4 million in 2025, then gained by 7.94% to $688.0 million in 2026.
- Per Business Quant, the three latest TECH Current Assets figures stand at $688.0 million (Q1 2026), $637.4 million (Q4 2025), and $609.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 688.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 688.05 Mn |
| Dec 31, 2025 | 637.43 Mn |
| Sep 30, 2025 | 609.51 Mn |
| Jun 30, 2025 | 608.30 Mn |
| Mar 31, 2025 | 627.24 Mn |
| Dec 31, 2024 | 634.64 Mn |
| Sep 30, 2024 | 648.57 Mn |
| Jun 30, 2024 | 617.42 Mn |
| Mar 31, 2024 | 610.65 Mn |
| Dec 31, 2023 | 590.64 Mn |
| Sep 30, 2023 | 591.48 Mn |
| Jun 30, 2023 | 621.48 Mn |
| Mar 31, 2023 | 571.00 Mn |
| Dec 31, 2022 | 565.18 Mn |
| Sep 30, 2022 | 552.03 Mn |
| Jun 30, 2022 | 605.56 Mn |
| Mar 31, 2022 | 593.11 Mn |
| Dec 31, 2021 | 590.23 Mn |
| Sep 30, 2021 | 543.75 Mn |
| Jun 30, 2021 | 510.61 Mn |